- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/00 - Drugs for disorders of the respiratory system
Patent holdings for IPC class A61P 11/00
Total number of patents in this class: 11015
10-year publication summary
|
378
|
323
|
599
|
619
|
720
|
1211
|
1023
|
1141
|
752
|
443
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
289 |
| Chiesi Farmaceutici S.p.A. | 969 |
174 |
| Boehringer Ingelheim International GmbH | 4650 |
158 |
| AstraZeneca AB | 2909 |
156 |
| Vertex Pharmaceuticals Incorporated | 1597 |
116 |
| Novartis AG | 10849 |
113 |
| Daiichi Sankyo Company, Limited | 1869 |
72 |
| F. Hoffmann-La Roche AG | 7925 |
71 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
63 |
| Genentech, Inc. | 3976 |
56 |
| Bristol-myers Squibb Company | 4898 |
54 |
| Takeda Pharmaceutical Company Limited | 2713 |
54 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
51 |
| The Regents of the University of California | 19918 |
50 |
| Bayer AG | 3330 |
47 |
| Bayer Pharma AG | 1052 |
45 |
| Theravance Biopharma R&D IP, LLC | 458 |
44 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3151 |
43 |
| Board of Regents, The University of Texas System | 5793 |
37 |
| Centre National de La Recherche Scientifique | 10418 |
35 |
| Other owners | 9287 |